These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4848602)

  • 1. [Effect of the inhibitor of glucose utilization, isolated from serum of patients in uremia, upon morphology and membrane permeability of erythrocytes (author's transl)].
    Gajdos M; Dzúrik R
    Bratisl Lek Listy; 1974; 62(1):29-34. PubMed ID: 4848602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of uremic middle molecules on the activity of erythrocyte lactate dehydrogenase (LDH)].
    Severini G; Malaguti-Aliberti L
    Ann Ist Super Sanita; 1985; 21(3):357-61. PubMed ID: 3834809
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic processes in the erythrocytes in disordered kidney function].
    Shepotinovskiĭ VI
    Urol Nefrol (Mosk); 1983; (3):62-6. PubMed ID: 6224339
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the adenine nucleotides metabolism in uremic erythrocyte (author's transl)].
    Sawada K
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1193-205. PubMed ID: 541880
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of dialysate fractions on glucose metabolism of erythrocytes (author's transl)].
    Shitomoto M; Matsuo T; Otsuji S
    Rinsho Byori; 1977 Aug; 25(8):630-2. PubMed ID: 916251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on erythrocyte metabolism in chronic kidney diseases].
    Buscarini L
    Folia Haematol (Frankf); 1964; 9(3):384-9. PubMed ID: 4171021
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzyme activities in the erythrocytes of patients with hemolysis (author's transl)].
    Labar B; Nazor A; Reiner Z; Popijac S; Polovina J
    Lijec Vjesn; 1979 Feb; 101(2):101-4. PubMed ID: 459668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enzyme activities in the erythrocytes of patients with indirect hyperbilirubinemia (author's transl)].
    Labar B; Nazor A; Reiner Z; Polovina J; Popijac S
    Lijec Vjesn; 1978 Oct; 100(10):615-7. PubMed ID: 745498
    [No Abstract]   [Full Text] [Related]  

  • 9. [The determination of the activity of acid phosphatase variants in the erythrocyte (author's transl)].
    Weippl G; Bluschke B
    Wien Klin Wochenschr; 1973 Dec; 85(52):862-3. PubMed ID: 4770605
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of the phenotypes of several erythrocytic enzymes by cellulose acetate electrophoresis].
    Le Gall JY; Rolland JP; Mubamba C
    Ann Biol Clin (Paris); 1975; 33(6):443-51. PubMed ID: 1227349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDH activity of red cells in chronic renal failure.
    Melissinos K; Drivas G; Vlassopoulos K
    Clin Chim Acta; 1972 Aug; 40(1):165-9. PubMed ID: 5056625
    [No Abstract]   [Full Text] [Related]  

  • 12. Red cell enzyme polymorphisms in Punjabis in North India.
    Papiha SS; Roberts DF; Wig NN; Singh S
    Am J Phys Anthropol; 1972 Sep; 37(2):293-9. PubMed ID: 5085502
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erythrocyte and serum enzymotypes in a group of Kurds].
    Vergnes H; Gherardi M
    Ann Genet; 1971 Sep; 14(3):199-205. PubMed ID: 5315466
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity and identification of red cell acid phosphatase phenotypes in cord blood (author's transl)].
    Weippl G; Bluschke B
    Padiatr Padol; 1974; 9(2):109-11. PubMed ID: 4823691
    [No Abstract]   [Full Text] [Related]  

  • 15. Red cell and serum proteins of talapoin, patas and vervet monkeys.
    Barnicot NA; Hewett-Emmett D
    Folia Primatol (Basel); 1971; 15(2):65-76. PubMed ID: 5005746
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo incorporation of iodopyracet into erythrocytes of healthy and azotemic patients.
    Wilson DM; Schwartz FD
    J Lab Clin Med; 1968 Dec; 72(6):951-7. PubMed ID: 5723118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of red blood cell glucose utilization in uremia].
    Gajdos M; Dzúrik R
    Vnitr Lek; 1974 Oct; 20(10):974-82. PubMed ID: 4420983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intraerythrocytic enzymatic polymorphism. General concept and clinical interest (author's transl)].
    Vives-Corrons JL; Garcia Sanmiguel J; Brugues MR; Rozman C
    Sangre (Barc); 1974; 19(2):133-52. PubMed ID: 4605758
    [No Abstract]   [Full Text] [Related]  

  • 19. [The significance of transcellular transport kinetics of urea and creatinine for haemodialysis (author's transl)].
    Zimmermann E; Pölz E
    Wien Klin Wochenschr; 1981 Sep; 93(16):519-21. PubMed ID: 7303697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythrocytic acid phosphatase isoenzyme patterns in Down's syndrome (author's transl)].
    Mato JM; Sordo MT; Serrano Rios M
    Sangre (Barc); 1975; 20(1):29-32. PubMed ID: 123660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.